NY-ESTÉE-LAUDER
14.9.2022 22:31:34 CEST | Business Wire | Press release
Today, Executive Chairman William P. Lauder and President and Chief Executive Officer Fabrizio Freda of The Estée Lauder Companies Inc. (NYSE:EL) (“ELC”) announced an organizational evolution across its brand portfolio to strategically position the company for long-term, sustainable growth in a fast-paced evolving global landscape.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220914005700/en/
Jane Hertzmark Hudis, Executive Group President, The Estée Lauder Companies (Photo: Business Wire)
Effective September 1, 2022, the company’s brand portfolio evolved into two brand clusters led by Jane Hertzmark Hudis, Executive Group President, and Stéphane de La Faverie, who has been promoted to Executive Group President. This new brand leadership structure is designed to ensure continued portfolio-wide alignment, enabling the business to focus on the greatest areas of opportunity. Jane and Stéphane will continue to report directly to Fabrizio Freda.
“This evolution further positions The Estée Lauder Companies’ brands to win with consumers in a complex and continuously changing beauty landscape, while elevating our internal talent bench and organizational planning to position us well to deliver on the company’s long-term strategy with agility,” said Fabrizio Freda. “The strength of our portfolio reflects the strength of our leadership team, and this evolution leverages the track record and high potential of each leader to take our business to even greater heights in the future.”
Building upon their enterprise-wide leadership responsibilities, Jane and Stéphane, in partnership with the Brand Presidents, will oversee their brands’ businesses, equity and innovation, continuing to work in close alignment with all internal functions and regions. Additionally, they will work closely with brand and value chain leaders to drive the strategy and growth plans for the company’s product categories and key subcategories.
“We have been and will continue to be a brand-led company. This exciting update to the organization will further enable our brands’ industry leadership,” said William P. Lauder. “Leveraging ELC’s internal talent pipeline globally underscores our commitment to create new professional development and career advancement opportunities for the next generation of leaders across our organization.”
This organizational evolution aligns with ELC’s forward-looking corporate strategy and Compass to accelerate the company’s ability to deliver now while simultaneously preparing for the future. The company’s top brand leaders are organizationally aligned in a management structure designed to promote cross-brand synergies and advance development at multiple levels of the organization. In line with the company’s internal talent vision, this announcement also includes the appointment of several leaders to elevated brand roles within the clusters of Jane and Stéphane.
Executive Group President Jane Hertzmark Hudis will continue leading one of the company’s brand clusters, with a portfolio of brands that includes: La Mer and Bobbi Brown; TOM FORD BEAUTY; M·A·C; Clinique and Origins; Aveda; Bumble and bumble; and Dr.Jart+. Jane will also continue her enterprise-wide executive leadership of skin care and hair care, which are important growth-driving categories for our company. All the current brand leaders will remain the same, with the exception of Sandra Main taking direct responsibility of La Mer. In addition, Jane will continue as an executive sponsor for key strategic enterprise-wide priorities, including initiatives focused on marketing excellence and winning with Chinese consumers.
As one of the most accomplished, visionary executives in prestige and luxury beauty, Jane has a proven track record of leading, building, and transforming global brands to achieve outstanding broad-based growth. Jane will leverage her tenured expertise, including her vast knowledge of China, luxury beauty, and consumer-centric local relevance, to further enable her brand portfolio to win across categories, regions, and channels.
Jane is a passionate advocate of leadership development, mentorship, and women’s advancement. In addition to her enterprise-wide responsibilities at the company, Jane co-founded The Estée Lauder Companies’ Women’s Leadership Network (“WLN”) in 2017 to inspire and engage women across the organization, helping them become exceptional leaders and mentors. Under Jane’s co-executive sponsorship, WLN has become the company’s largest employee resource group with a presence in every region.
As Executive Group President, Stéphane de La Faverie will continue to lead one of the company’s brand clusters including Estée Lauder and AERIN Beauty; Jo Malone London; Le Labo; KILIAN PARIS, Editions de Parfums Frederic Malle, Darphin Paris and LAB Series; and DECIEM (The Ordinary, NIOD, and Avestan). Additionally, Stéphane will add ELC’s California-based brands to his portfolio – Too Faced; Smashbox and GLAMGLOW – expanding his category leadership to now include makeup, in addition to fragrance and subcategories of home, bath and body, and men’s skin care and grooming. With the exception of Estée Lauder, all the leaders of the brands now in Stéphane’s portfolio remain the same. Stéphane will also continue to drive integrated planning and end-to-end business operations enterprise-wide.
Stéphane’s promotion to Executive Group President reflects his outstanding track record of building successful global brands and his deep expertise across categories and channels, helping build fragrance as a powerful engine of growth for the company, and leading the Estée Lauder brand to be one of the world’s most beloved prestige beauty brands.
Stéphane’s strength as an inclusive and empathic leader, and his ability to balance emotional inspiration, authenticity and strategic insights to drive long-term, sustainable growth, have helped him successfully build his portfolio of brands and nurture a winning leadership team.
Additional Brand Leadership Updates
- Justin Boxford has been appointed Global Brand President, Estée Lauder. He will report to Stéphane. A separate announcement on Justin’s appointment will be shared in the coming days.
- Sandra Main, Global Brand President, La Mer and Bobbi Brown, will assume direct leadership of La Mer and will oversee Bobbi Brown until a new leader is named. Sandra will continue reporting to Jane.
- Michelle Freyre has been promoted to Global Brand President, Clinique and Origins, expanding her brand oversight. Michelle will report to Jane.
- Amber Garrison, who assumed the role of Global Brand President, Origins in July 2022, will continue as a member of Jane’s leadership team and report to Michelle Freyre.
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, LAB Series, Origins, M·A·C, La Mer, Bobbi Brown, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD BEAUTY, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.
ELC-L
ELC-C
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220914005700/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
